DeepMed Research

University of British Columbia

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1908-01-01

Employees: 10K

Market Cap: -

Website: http://www.ubc.ca

Clinical Trials

Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Phase 2

Recruiting

Conditions: Opioid Use Disorder

Interventions: Drug: Buprenorphine/naloxone
Drug: Hydromorphone

First Posted Date: 2020-01-21

Last Posted Date: 2024-06-11

Lead Sponsor: University of British Columbia

Target Recruit Count: 50

Registration Number: NCT04234191

Locations: 🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada

Arm Boot Camp Study: Evaluation of a Program to Increase Upper Limb Recovery After Stroke

Not Applicable

Completed

Conditions: Stroke
Central Nervous System Diseases
Cerebrovascular Disorders
Cardiovascular Diseases
Cerebral Infarction
Brain Diseases
Infarction
Brain Infarction
Vascular Diseases
Nervous System Diseases

Interventions: Behavioral: Arm Boot Camp

First Posted Date: 2020-01-18

Last Posted Date: 2023-02-03

Lead Sponsor: University of British Columbia

Target Recruit Count: 62

Registration Number: NCT04232163

Locations: 🇨🇦
Dalhousie University, Halifax, Nova Scotia, Canada
🇨🇦
GF Strong Rehab Centre, Vancouver, British Columbia, Canada
🇨🇦
University of Calgary, Calgary, Alberta, Canada

and more 4 locations

Predictors of Outcome After Perioperative Stroke

Conditions: Stroke, Acute
Perioperative Complication

First Posted Date: 2020-01-02

Last Posted Date: 2022-04-15

Lead Sponsor: University of British Columbia

Target Recruit Count: 20000

Registration Number: NCT04214613

Locations: 🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada

Noise in the OR at Induction: Patient and Anesthesiologists Perceptions

Not Applicable

Completed

Conditions: Patient Satisfaction
Noise Exposure
Surgery
Anesthesia

Interventions: Behavioral: Noise Reduction Education

First Posted Date: 2019-12-19

Last Posted Date: 2020-06-04

Lead Sponsor: University of British Columbia

Target Recruit Count: 400

Registration Number: NCT04204785

Locations: 🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada

FMT for Remission of Active Ulcerative Colitis in Adults

Phase 2

Withdrawn

Conditions: Inflammatory Bowel Diseases
Ulcerative Colitis

Interventions: Other: Placebo oral
Biological: FMT oral
Other: Placebo enema
Biological: FMT enema

First Posted Date: 2019-12-17

Last Posted Date: 2023-05-10

Lead Sponsor: University of British Columbia

Registration Number: NCT04202211

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦
Royal Jubilee Hospital, Victoria, British Columbia, Canada
🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada

Exogenous Ketones in Type 2 Diabetes

Not Applicable

Completed

Conditions: Ketosis
Type 2 Diabetes

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Ketone monoester

First Posted Date: 2019-12-11

Last Posted Date: 2023-12-11

Lead Sponsor: University of British Columbia

Target Recruit Count: 19

Registration Number: NCT04194450

Locations: 🇨🇦
University of British Columbia, Okanagan, Kelowna, British Columbia, Canada

Hearts in Rhythm Organization (HiRO)National Registry and Bio Bank

Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Hypertrophic Cardiomyopathy (HCM)
Sudden Cardiac Arrest
Sudden Arrhythmic Death Syndrome
Long QT Syndrome (LQTS)
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

First Posted Date: 2019-12-06

Last Posted Date: 2022-11-03

Lead Sponsor: University of British Columbia

Target Recruit Count: 10000

Registration Number: NCT04189822

Locations: 🇨🇦
University of British Columbia/St. Paul's Hospital, Vancouver, British Columbia, Canada

Oral Magnesium Supplementation in Athletes With Premature Ventricular Contractions or Premature Atrial Contractions.

Not Applicable

Conditions: Atrial Premature Complexes
Ventricular Premature Complexes

Interventions: Dietary Supplement: Magnesium glycinate
Other: Placebo

First Posted Date: 2019-12-05

Last Posted Date: 2020-07-29

Lead Sponsor: University of British Columbia

Target Recruit Count: 50

Registration Number: NCT04186728

Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2.

Phase 2

Conditions: Scar
Hypertrophic Scar
Skin Graft Scar
Skin Graft Complications
Keloid
Cicatrix
Donor Site Complication

Interventions: Drug: Fibrosis-Inhibiting-Compound-FS2
Other: Vehicle moisture balancing base

First Posted Date: 2019-12-04

Last Posted Date: 2019-12-17

Lead Sponsor: University of British Columbia

Target Recruit Count: 50

Registration Number: NCT04186273

Locations: 🇨🇦
VGH Burn Unit, Vancouver, British Columbia, Canada

Long-Term Follow-Up of HPV FOCAL Participants

Active, not recruiting

Conditions: Cervical Cancer

Interventions: Other: HPV and cytology co-testing (via Liquid based collection device)

First Posted Date: 2019-12-04

Last Posted Date: 2022-11-01

Lead Sponsor: University of British Columbia

Target Recruit Count: 1710

Registration Number: NCT04185389

Locations: 🇨🇦
Women's Health Research Institute, Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy